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cAMP signaling in the brain mediates several higher order neural
processes. Hyperpolarization-activated cyclic nucleotide-gated (HCN)
channels directly bind cAMP through their cytoplasmic cyclic nucleo-
tide binding domain (CNBD), thus playing a unique role in brain
function. Neuronal HCN channels are also regulated by tetratrico-
peptide repeat-containing Rab8b interacting protein (TRIP8b), an
auxiliary subunit that antagonizes the effects of cAMP by interact-
ing with the channel CNBD. To unravel the molecular mechanisms
underlying the dual regulation of HCN channel activity by cAMP/
TRIP8b,wedetermined theNMRsolution structure of theHCN2 chan-
nel CNBD in the cAMP-free form and mapped on it the TRIP8b inter-
action site. We reconstruct here the full conformational changes
inducedby cAMPbinding to theHCNchannelCNBD.Our results show
that TRIP8b does not compete with cAMP for the same binding re-
gion; rather, it exerts its inhibitory action through an allosteric mech-
anism, preventing the cAMP-induced conformational changes in the
HCN channel CNBD.
Hyperpolarization-activated cyclic nucleotide-gated (HCN1–4)channels are the molecular determinants of the h-current
(Ih), which regulates critical neuronal properties, including mem-
brane resting potential, dendritic excitability, and intrinsic rhyth-
micity (1). HCN channels are dually regulated by voltage and by
binding of cAMP to the cyclic nucleotide binding domain (CNBD),
which is found on the cytoplasmic C-terminal tail of the channel.
The CNBD exerts a tonic inhibition on the channel pore, with
the opening transition of the channel being allosterically coupled
to the conformational changes in the CNBD induced by cAMP
binding (2). Thus, the closed-to-open transition of the channel is
thought to reflect the transition from the cAMP-free conforma-
tion to the cAMP-bound conformation of the CNBD, which sta-
bilize, respectively, the closed and open states of the channel (2, 3).
The C-linker, an α-helical folded domain that connects the CNBD
to the pore region, conveys the regulation of channel gating from
the CNBD to the pore (4–6). As a result of this allosteric mecha-
nism, the binding of cAMP shifts the voltage dependence of the
HCN channel opening to more positive potentials and increases
maximal Ih at extreme negative voltages, where voltage gating
is complete.
In addition to cAMP, HCN channels in the brain are regulated
by auxiliary proteins, such as TRIP8b, a cytosolic β-subunit of
neuronal HCN channels, which inhibits channel activation by
antagonizing the effects of cAMP (7–9). We have previously
shown that TRIP8bcore, an 80-aa sequence located in the TRIP8b
protein core that directly interacts with the C-linker/CNBD region
of HCN channels, is necessary and sufficient to prevent all of the
effects of cAMP on the channel (10, 11). TRIP8bcore decreases
both the sensitivity of the channel to cAMP [half maximal
concentration (k1/2)] and the efficacy of cAMP in inducing
channel opening [half activation voltage (V1/2)]; conversely,
cAMP binding inhibits these actions of TRIP8b. These mutually
antagonistic effects are well described by a cyclic allosteric model
in which TRIP8b binding reduces the affinity of the channel for
cAMP, with the affinity of the open state for cAMP being re-
duced to a greater extent than the cAMP affinity of the closed
state (11).
A second important action of TRIP8b is to reduce maximal
current through HCN channels in the absence of cAMP (11). As
a consequence, application of cAMP produces a larger increase in
maximal Ih in the presence of TRIP8b than in its absence. The
observation that TRIP8b exerts opposing influences on the two
major actions of cAMP on HCN channel function, namely, reduces
the effect of cAMP to shift the voltage dependence of channel
gating but enhances the effect of cAMP to increase maximal cur-
rent, has important implications for the ability of cAMP to mod-
ulate neuronal excitability in vivo. Thus, the relative extent by
which neuromodulatory transmitters alter maximal Ih or shift the
voltage dependence of HCN channel gating can vary widely among
distinct classes of neurons (12–14). The differential expression of
TRIP8b may provide a mechanistic explanation for this finding,
because in neurons with high levels of TRIP8b expression, cAMP
will exert a larger action to enhance maximal current, and a smaller
action to alter the voltage dependence of channel gating, compared
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with neurons in which TRIP8b expression is low. Such fine-tuning
broadens the range of physiological actions that cAMP can exert to
modulate neuronal firing.
In the present study, we address the structural basis for the
mutually antagonistic effects of cAMP and TRIP8b on HCN
channel function. Although our previous biochemical and electro-
physiological data strongly support the hypothesis that TRIP8b and
cAMP binding sites do not overlap, direct structural information
on the TRIP8b–CNBD complex is required to validate the allo-
steric antagonism model of interaction between the two ligands. A
plausible hypothesis for the antagonistic effect of TRIP8b and
cAMP is that each of the two ligands stabilizes the CNBD in
a conformation that decreases the affinity for the other. To test
this hypothesis, we first generated the 3D structure of the cAMP-
free HCN2 channel CNBD using solution NMR spectroscopy
and then characterized its interaction with the TRIP8bcore frag-
ment. By comparing the cAMP-free with the available cAMP-
bound HCN2 channel CNBD structure (15, 16), we reconstruct
the full conformational changes induced by cAMP binding, re-
vealing critical transitions occurring in the P- and C-helices of
the CNBD, and further highlighting the role of the N-terminal
helical bundle in transducing the movements of the CNBD to
the channel pore. We next identify, through NMR titration, site-
directed mutagenesis, and biochemical interaction assays, the
binding site of TRIP8bcore on the cAMP-free form of the HCN2
channel CNBD. Our results demonstrate that cAMP and TRIP8b
do not directly compete for the same binding region and support a
model of mutual allosteric inhibition between cAMP and TRIP8b.
Finally, our results clarify the mechanism by which TRIP8b
antagonizes the effect of cAMP on channel gating: TRIP8b directly
interacts with two mobile elements that drive the ligand-induced
conformational changes in the CNBD. TRIP8b binding to the
CNBD therefore prevents the cAMP-induced transition and sta-
bilizes the channel in the cAMP-free conformation.
Results
cAMP Destabilizes the TRIP8bcore–HCN2 C-Linker/CNBD Protein Complex.
Electrophysiological experiments have shown that the antagonistic
role of TRIP8b on the cAMP-dependent effects on HCN channel
activity is due to the TRIP8bcore fragment, the 80-aa core domain
of the full-length TRIP8b protein that interacts with the C-linker/
CNBD domain of the channels (10, 11). Furthermore, previous
electrophysiological analysis and biochemical assays have suggested
that native TRIP8b preferentially interacts with full-length HCN1
or HCN2 in the absence of cAMP, and that binding activity
decreases with increasing cAMP concentration (11, 17). We
therefore tested whether this behavior is also maintained in
vitro between the isolated HCN2 C-linker/CNBD and TRIP8bcore
protein fragments. We coexpressed in Escherichia coli the His6-
maltose binding protein (MBP)–tagged C-linker/CNBD (here-
after, the CNBDC-linker) and the Streptactin-binding (Strep)-tagged
TRIP8bcore protein fragments. The bacterial lysate was supple-
mented with increasing cAMP concentrations (from 0 to 1
mM), and the complex was subsequently purified using a nickel
affinity column. Increasing cAMP concentration in the lysate
decreased the amount of TRIP8bcore protein copurified with the
CNBDC-linker, revealing the destabilizing effect of the cyclic nucle-
otide on TRIP8b–CNBD interaction (Fig. S1A). These results
confirm that TRIP8bcore and cAMP are competing for binding to
the CNBD and that TRIP8b preferentially binds the cAMP-free
conformation of the CNBD. The question remains as to whether
a direct (for the same binding site) or indirect (allosteric) compe-
tition occurs between the two ligands. To answer this question, we
used solution NMR spectroscopy to obtain the 3D structure of the
HCN2 CNBD in the cAMP-free conformation and, subsequently,
to map the TRIP8b binding site on the channel’s CNBD.
Biophysical Characterization of the TRIP8bcore–CNBD Protein Complex.
A shorter construct lacking the first three α-helices (αA′–αC′) of
the HCN2 C-linker region (hereafter, the CNBD) was prepared to
prevent the C-linker–driven tetramerization of the protein, which
occurs at high concentrations (15, 18), and to reduce the fragment
to a size within the optimal range for solution NMR experiments
(17.9 kDa). To verify that the partial removal of the C-linker
domain did not affect the interaction with TRIP8bcore, we first
coexpressed the His6-MBP–tagged CNBD with TRIP8bcore in
E. coli and purified the complex using the TRIP8bcore Strep tag.
As shown in Fig. S1B, the CNBD efficiently copurifies with
TRIP8bcore, confirming that neither the complete C-linker
domain nor the oligomerization of the HCN2 CNBD is re-
quired for the interaction with the TRIP8bcore fragment. We
further determined the thermodynamic parameters of this in-
teraction by isothermal titration calorimetry (ITC). Fig. S1C
shows that the interaction is exothermic. Analysis of the binding
curve yields a stoichiometry of n = 0.98 ± 0.01 and a calculated
dissociation constant, Kd, of 1.30 ± 0.06 μM (n = 3). This finding is
in agreement with the 1:1 stoichiometry recently determined for
HCN2 and the full-length TRIP8b, using a single-molecule fluo-
rescence bleaching method (19).
Structure of the Human HCN2 CNBD in the cAMP-Free Form and Ligand-
Induced Conformational Changes. The structure of HCN2 CNBD in
the cAMP-free form adopts the typical overall fold of CNBDs (20)
(Fig. 1A and Fig. S2 A and B). Such a fold comprises an anti-
parallel β-roll that includes, between strands β6 and β7, the
phosphate binding cassette (PBC), which forms the cAMP
binding pocket (16); an N-terminal helical bundle, composed of
an antiparallel helix–turn–helix motif formed by helices αE′
and αA; and two C-terminal helices, αB and αC, located at the
Fig. 1. cAMP-free structure of the human HCN2 CNBD and comparison with
the bound structure. (A) Ribbon representation of the cAMP-free CNBD structure
(orange). For better visualization of the structure, only one conformation of the
unstructured C-terminal part of the C-helix (residues 659–663) is shown, whereas
the unfolded region at the N terminus of the construct (residues 521–532) and
the stretch following the C-helix (residues 664–672) are not shown. Secondary
structure elements are labeled. (B) Ribbon representation of the X-ray cAMP-
bound CNBD structure (gray) [PDB ID code 1Q5O (ref. 16)]. The cAMP molecule
is shown in stick representation in black. (C) Superposition of the cAMP-free
and cAMP-bound structures of the CNBD.
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distal end of the CNBD. A comparison of the cAMP-free and
cAMP-bound CNBD structures (Fig. 1 A and B) reveals clear
differences between the two states of the HCN2 channel’s
CNBD (Fig. 1C), however. In particular, a number of major
rearrangements are observed in the helical components of the
CNBD, whereas less pronounced differences are observed in
the β-roll. Indeed, the β-strands undergo only minor displacement
upon ligand binding [Fig. 1C; Cα rmsd of 0.78 Å between cAMP-
free (orange) and cAMP-bound forms (gray)]. In striking con-
trast, substantial changes occur in the helical components of the
CNBD, as illustrated in detail in Fig. 2. Within the PBC element
(Fig. 2 A and B), cAMP binding triggers the formation of the
P-helix (residues 609–615; highlighted in red in Fig. 2B). The folding
of the P-helix is instrumental in forcing residue Leu612 into a new
configuration, which allows Phe638 located in the B-helix to ap-
proach the β-roll (residue movements highlighted by arrows in Fig.
2A; the B-helix moves by about 4.5 Å). Thus, following the dis-
placement of Leu612, the B-helix moves toward the cavity, together
with the C-helix (Fig. 2C), with the two helices moving as rigid
bodies toward the core of the CNBD (the angle between αB and
αC is 125.05° in the cAMP-free form and 123.83° in the cAMP-
bound form).
The structure of the cAMP-free HCN2 CNBD also reveals
that the C-terminal region of the C-helix (residues 659–663) is
unstructured (Fig. 2C), in agreement with the lack of medium-
and long-range NOEs involving these residues (Fig. S2C). Res-
idues 659–663 featured small {1H}-15N–NOE values (Fig. S2D),
indicating that they experienced dynamics on the subnanosecond
time scale in the cAMP-free form, which is consistent with a
random-coil conformation. The C-helix is one helical turn longer
in the cAMP-bound form (Fig. 2D). Thus, the formation of tight
contacts between the side chains of Arg659 and Ile663 and the
cAMP purine ring (16, 21) induces conformational changes in
the backbone of the C-terminal part of the C-helix, which are
critical in stabilizing the interaction between the cAMP molecule
and the β-roll cavity.
Finally, the rearrangement of the PBC also indirectly induces
the movement of the N-terminal helical bundle. By moving
closer to the β-roll, the C-helix sterically displaces the N-terminal
helical bundle, as shown in Fig. 2E. As a result, the E′-helix
undergoes a major displacement, moving upward by about 5.5 Å;
the loop (residues 543–549) connecting the E′- and A-helices is
displaced upward by 5 Å, and forms a new helix (αF′) in the
cAMP-bound form (Fig. 2F). Although the F′-helix is not pres-
ent in the cAMP-free state, the analysis of 13C chemical shifts,
which reflect local conformation and thus secondary structural
elements, nevertheless shows that three residues located in the
corresponding loop (residues 543–545) do have a marked helix
propensity.
In conclusion, the comparison between the cAMP-free and
cAMP-bound structures of the HCN2 channel CNBD allows the
first detailed description, to our knowledge, of the conforma-
tional changes induced by cyclic nucleotide binding in this pro-
tein. Such comparison highlights how, similar to other CNBDs,
the binding of the cyclic nucleotide to the PBC causes the tight-
ening of this element, which, in turn, drives the movement of the
helices at both the N and C termini of the β-roll (Movie S1).
Fig. 2. Conformational changes in the helical components following cyclic nucleotide binding to the CNBD. (A) Close-up view of the PBC. The phosphate-
sugar moiety of cAMP binds to the PBC, inducing its rearrangement. In the absence of cAMP, Leu612 of PBC occupies the space that is filled by Phe638 of the
B-helix in the cAMP-bound conformation. (B) Highlighted in red is the portion of the PBC loop that folds into αP upon cAMP binding. (C) Translational
movement of the B- and C-helices moving as a rigid body toward the cAMP molecule bound to the PBC. (D) Folding of the C-terminal portion of the C-helix
from Arg659 to Ile663 (shown in red). cAMP apolar interactions with the side chains of Arg659 and Ile663 are represented as dotted spheres. (E) Close-up view of
the N-terminal helical bundle (αE′–turn–αA). The cAMP-induced movement of the B- and C-helices element forces the N-terminal helical bundle to adopt a
new position. (F) Red-marked loop between αE′ and αA folds into αF′.
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TRIP8b Binding Region on the CNBD.Having determined the structure
of the CNBD in the cAMP-free form, we next carried out
NMR titrations to identify the binding region of TRIP8b on
the HCN2 CNBD. We acquired a series of [1H, 15N] hetero-
nuclear single quantum coherence spectra of the 15N-labeled
CNBD in the presence of different concentrations of unlabeled
TRIP8bcore. The addition of increasing amounts of TRIP8bcore
induced a progressive reduction in the intensity of a set of amide
proton (NH) signals of the free CNBD and the appearance of
a new set of signals of the protein in complex with TRIP8bcore. At
a ratio of [TRIP8bcore]/[CNBD] of 2.0, a single set of
NH signals
was observed (Fig. S3).
A complete list of the residues that experience a different
chemical shift upon addition of TRIP8bcore is presented in Table
S1. The majority of these residues cluster in one region, forming
a continuous surface exposed to the solvent (Fig. 3). This region
comprises the loop between αE′ and αA of the N-terminal helical
bundle (hereafter, the “N-bundle loop”) and the C-helix. In-
terestingly, in the quaternary structure of the cAMP-bound form
of the HCN2 channel C-linker/CNBD fragment (Fig. S4), the
identified region is not located at the subunit interface but remains
fully exposed to the solvent, and thus accessible to the TRIP8b
protein both in the cAMP-free and cAMP-bound forms of the
CNBD. This finding is consistent with our previous electrophysi-
ological results showing that TRIP8b binding can also occur in the
presence of a saturating concentration of cAMP (11).
A few additional residues, experiencing a different chemical
shift upon addition of TRIP8core, are located in the β-roll and are
essentially buried. Finally, three residues in the short stretch that
follows the C-helix (Gly664, Lys665, and Ile669) were also per-
turbed by the addition of TRIP8core. Because chemical shift
changes at a given residue upon addition of a binding partner do
not necessarily indicate a direct contribution of that residue to
the binding interaction but can also be the consequence of local
structural rearrangements [a behavior observed in a number of
other protein–protein complexes characterized by NMR (22–24)],
we next sought to obtain direct biochemical evidence implicating
the solvent-exposed region identified in Fig. 3 as the prime can-
didate for mediating the interaction between TRIP8bcore and the
HCN2 channel CNBD.
Biochemical Validation of TRIP8b Binding Site on the CNBD. To con-
firm that the N-bundle loop and C-helix regions directly mediate
TRIP8b–CNBD interactions, we performed site-directed mutagenesis
and biochemical binding assays by affinity-purifying the mo-
lecular complex from E. coli cells coexpressing the two partner
proteins. Deletion of the N-bundle loop (construct CNBDΔN,
comprising residues 550–672) or of the C-helix (construct
CNBDΔC, comprising residues 521–645) completely abolished
the formation of the complex between the CNBD and TRIP8bcore
(Fig. 4). To rule out the possibility that the loss of binding may be
due to a global loss of folding of the truncated CNBD constructs,
we further confirmed using ITC that the CNBDΔN construct
retained the same cAMP binding properties of the WT (Table S2).
Because the absence of the C-helix prevents cAMP binding (2, 21),
the correct global folding of the CNBDΔC construct was verified
using NMR (Fig. S5). In addition, lack of binding activity to
TRIP8bcore was further verified for both CNBD truncation con-
structs using ITC (Table S2). Overall, our results demonstrate that
both the N-bundle loop and the C-helix are required for the for-
mation of the TRIP8b binding region. Moreover, our data show
that each of these elements is necessary but not sufficient for
the binding.
Fig. 3. Proposed binding region for TRIP8bcore on the HCN2 CNBD. A ribbon
representation of the CNBD shows in red the residues whose amide proton (NH)
signals were perturbed upon the addition of TRIP8bcore. van der Waals vol-
umes are reported for the perturbed residues in the N-bundle loop and in
the C-helix. For simplicity, only one conformation of the unstructured region
of the C-helix (residues 659–663) is shown. The N- and C-terminal regions of
the construct are omitted as in Fig. 1.
Fig. 4. Contribution of the N-bundle loop and the C-helix/stretch to the
TRIP8b binding site. (A, Lower) Bacterial lysates from cells coexpressing
Strep-tagged TRIP8bcore (blue arrowhead) and His6-MBP–tagged CNBD WT
and mutants (green arrowhead) were loaded onto a Strep-tactin affinity
column for Strep-tag purification. Eluted samples were analyzed by Coo-
massie Blue staining following SDS/PAGE separation. Numbers on the left
indicate molecular mass markers (kDa), loaded in the first lane. Lane 1
contains CNBDΔN. Lane 2 contains CNBDΔC. Lanes 3–5 contain mutants
obtained by progressive truncation of the C-helix. A stop codon was in-
troduced after the following residues: Ala651 (lane 3), Ile657 (lane 4), and Ile663
(lane 5). Pro646 and Ile663 correspond to the first and last amino acids of the
C-helix, respectively. Lanes 6 and 7 contain mutants obtained by progressive
truncation of the stretch following the C-helix. A stop codon was introduced
after the following residues: Lys666 (lane 6) and Ile669 (lane 7). Lane 8 contains
K665E/K666E double-CNBD point mutant. (A, Upper) Sequence and cartoon
representation of the C-helix/stretch are shown. Arrows indicate the last
residue of the deletion constructs. Numbering of the arrows corresponds to
gel lanes. (B) Coomassie Blue staining of the bacterial lysates before Strep-
tactin affinity purification, showing an equivalent expression level of all the
mutant constructs tested. The green arrowhead indicates the His6-MBP–
tagged CNBD proteins. Lane numbers are as in A.
4 of 6 | www.pnas.org/cgi/doi/10.1073/pnas.1410389111 Saponaro et al.
Because the C-helix is rather long, comprising 18 residues in
total, we carried out additional mutagenesis experiments to identify
the residues essential for the interaction. To this end, we gradually
reintroduced the C-helix in the CNBDΔC fragment and tested the
resulting constructs for TRIP8bcore binding. Somewhat surpris-
ingly, reintroduction of the C-helix (up to residue Ile663) conferred
minimal binding activity to TRIP8bcore, whereas the interaction
with TRIP8bcore was restored only upon addition of the first three
residues of the stretch following the C-helix (GKK, residues 664–
666) (Fig. 4). Further addition of downstream residues (667–672)
did not improve the binding. We further investigated the role of
the two lysines in this stretch (Lys665 and Lys666) by mutating
them to glutamates. The inversion of charge strongly reduced
the binding of the double-mutant CNBD protein K665E/K666E to
TRIP8bcore, confirming the critical role of these two positively
charged residues for the interaction (Fig. 4). The proper folding of
the double-mutant protein was again assessed using ITC, which
confirmed that the K665E/K666E mutant retains cAMP binding
activity (Table S2). Of note, the somewhat higher Kd of the dou-
ble-point mutant compared with WT is likely to reflect the mu-
tation at position 665 because this residue is thought to contribute
a direct contact with cAMP in the HCN2 channel CNBD (21).
Discussion
In the present study, we provide direct structural information on
the HCN2 channel CNBD conformational transitions due to
cAMP binding and identify the specific TRIP8b binding site on
the channel’s CNBD.
We show here, for the first time to our knowledge, the experi-
mentally determined structure at a high resolution of the human
HCN2 channel CNBD in the cAMP-free form, which allows a
detailed characterization of all of the conformational transitions
that occur in the HCN channel CNBD upon cyclic nucleotide
binding. By comparing the cAMP-free and cAMP-bound struc-
tures, we show that cAMP binding promotes the following rear-
rangements in the channel’s CNBD: (i) folding of the P-helix
within the PBC element, located in the β6–β7 loop, which, in turn,
causes a repositioning of the hydrophobic residues occupying the
β-roll cavity; (ii) translational movement of the B- and C-helices
toward the β-roll and folding of the distal portion of the C-helix
due to its interaction with cAMP; and (iii) folding of the F′-helix
and upward displacement of the N-terminal helical bundle. The
latter displacement likely represents the key movement in the
transmission of the cAMP signal from the CNBD to the pore. In
HCN channels, the N-terminal helical bundle, which is a con-
served element in all CNBDs, comprises the last two helices (αE′
and αF′) of the C-linker, which is directly connected to the pore.
Although the precise movements of the HCN channel C-linker,
as well as how it affects the pore module, are not completely
understood (4, 5, 25), it is clear that the upward movement of the
N-terminal helical bundle is crucial in triggering the rearrange-
ment in the C-linker leading to pore opening. In this regard, the
HCN2 CNBD behaves in line with the universally conserved
mechanism governing CNBDs from several other prokaryotic
and eukaryotic proteins (20). Thus, the N-terminal helical bun-
dle is the key element in translating the activation mechanism of
several CNBD-containing enzymes, including PKA and EPAC,
and the bacterial CNG channel MloK1 (26–28).
We also provide direct structural evidence that the C-terminal
part of the C-helix in HCN channels is disordered in the absence
of cAMP. Its folding upon addition of cAMP is driven by the
formation of a hydrophobic stacking interaction between the side
chains of Arg659 and Ile663 of the C-helix and the adenosine ring
of the nucleotide (16, 21). Because these two key residues lo-
calize in the disordered region of the C-helix, the capture of the
ligand into the CNBD binding pocket in HCN channels requires
the stabilization of a dynamic element, a step that may affect the
affinity of the protein for cyclic nucleotides. Consistent with this
hypothesis, the prokaryotic homolog channel MloK1, which also
has a rigid C-helix in the cAMP-free form (28), has about 15-fold
lower affinity for cAMP than HCN2 (29).
Our results are consistent with previous data addressing the
conformation of the cAMP-free HCN channel CNBD. Although
an available structure of the HCN2 CNBD crystallized in the
cAMP-free state [Protein Data Bank (PDB) ID code 3FFQ (30)]
shows no major differences compared with the cAMP-bound
structures, likely due to the presence of bromide ions in the ligand
binding pocket, which stabilize the structure in a “cAMP-bound-
like” configuration (31), this structure suggests that cAMP-
dependent rearrangements might occur in the F′- and C-helices.
Moreover, evidence for structural rearrangements in these two
elements has been provided by transition metal ion FRET (30, 31).
Very recently, a structural model of the cAMP-free HCN4
CNBD was obtained using CS-Rosetta implemented with the ad-
dition of residual dipolar couplings [PDB ID code 2MNG (32)].
The overall structure of the HCN4 model resembles the NMR
solution structure of the cAMP-free HCN2 solved in this study,
highlighting the high degree of conservation of CNBD folding in
HCN channels. Nevertheless, the present experimentally de-
termined 3D structure shows some important differences with
respect to the HCN4 CS-Rosetta model: (i) the absence of the
P-helix in the PBC domain, (ii) a lower helical propensity of
the F′-helix, and (iii) a description of the dynamic of C-helix
in the cAMP-free state. Thus, the HCN2 structure presented
in this study provides the most comprehensive description to
date of the conformational changes that occur upon cAMP
binding to the HCN channel CNBD.
Using NMR titration and biochemical assays, we next identify
two elements in the HCN2 channel CNBD domain that are both
necessary for the interaction with TRIP8bcore. These elements
comprise a number of solvent-exposed residues (Table S1) likely
to be involved in the molecular recognition. In particular, the
two positively charged residues Lys665 and Lys666, located in the
stretch following the C-helix, have a critical role in protein com-
plex formation. Intriguingly, TRIP8bcore includes an acidic stretch
of residues (EEEFE) previously shown to be essential for the
functional interaction between TRIP8b and HCN channels (11).
Together, these findings suggest that the binding between the
C-helix/stretch and TRIP8b might be driven by electrostatic
interactions. The relevance of the stretch sequence immediately
following the C-helix in the regulation of channel activity is sup-
ported by its strong conservation among all four HCN isoforms (33).
Our work demonstrates that TRIP8b and cAMP do not com-
pete for the same binding site and provides definitive structural
evidence to validate the allosteric inhibition model recently pro-
posed (11). The binding of TRIP8bcore to the HCN2 CNBD affects
only a minor set of signals in the NMR spectra, suggesting that
no significant conformational changes occur in the overall CNBD
structure upon TRIP8bcore binding. We conclude that TRIP8b
allosterically antagonizes the action of cAMP by stabilizing the
cAMP-free conformation of the HCN channel CNBD. Among
the several mobile elements that we have identified in the cAMP-
free–to–cAMP-bound transition, we find that TRIP8b binding
blocks two solvent-exposed elements: the N-bundle loop and the
C-helix/stretch. These two elements form a single continuous
region, which is easily accessible in both the monomeric and the
tetrameric forms of the HCN channel C-linker/CNBD protein
fragment. Thus, TRIP8b hinders the cAMP-induced effects
on channel activity by two modalities: by blocking the move-
ment of the N-terminal helical bundle, which presumably
transmits the movement from the CNBD to the C-linker and
the pore, and by preventing the movement of the C-helix,
hampering its interaction with cAMP and thus its refolding. As
a consequence, when the CNBD is bound to TRIP8b, it has a
decreased affinity for cAMP, as recently estimated from elec-
trophysiological data (11).
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HCN channels are involved in the regulation of a number of
higher order neural processes, including sleep–wake transitions
and short- and long-term memory (34–36). Although HCN chan-
nels are expressed both in the brain and in the heart, where they
contribute to the regulation of cardiac rhythmicity (37, 38),
their interaction with the TRIP8b auxiliary subunit is unique to
the brain (39). Thus, in providing structural information on the
dual cAMP/TRIP8b modulation of HCN channel activity, our
work may ultimately lead to a better comprehension of the
molecular bases of neurological disorders linked to dysfunction
of the Ih conductance in neurons and to the design of drugs
specifically able to modulate HCN channel-mediated neural
processes.
Materials and Methods
Preparation of Proteins. Samples for NMR studies, as well as protein com-
plexes, were prepared as detailed in SI Materials and Methods.
ITC. Measurements were carried out at 25 °C using a MicroCal VP-ITC mi-
crocalorimeter (GE Healthcare). A detailed description of the measurements
is provided in SI Materials and Methods.
NMR Data and Structure Determination. NMR experiments were acquired on
a Bruker Avance II+ 800-MHz spectrometer equipped with a quadrupole
resonance (QXI-HCN) gradient probe and on a Bruker Avance III 600-MHz
NMR spectrometer equipped with a triple (TCI) resonance cryo-probe at
298 K. A detailed description of NMR experiments, data evaluation, and
structure calculation is provided in SI Materials and Methods.
The NMR titrationwas performedmaintaining the concentration of cAMP-
free HCN2 CNBD constant at 0.1 mM. Each of the titration points was pre-
pared independently by adding an aliquot of unlabeled TRIP8bcore to a so-
lution of 15N-CNBD until reaching a ratio of [TRIP8bcore]/[HCN2 CNBD] of 2.0.
CNBD in the complex with TRIP8bcore exchanges with the free protein at
rates slower than the chemical shift differences between the two forms (i.e.,
in the range of milliseconds).
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